Wilfred e. Jaeger

This profile gathers the share dealings of Wilfred e. Jaeger across 2 companies, led by Concert Pharmaceuticals, Inc. and Neuronetics, Inc. Over a trading history stretching from 27 May 2021 to 25 May 2023, the count stands at 6 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 30 May 2023, reports a share grant in Neuronetics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.